Perioperative sleep disturbance following mastectomy: A longitudinal investigation of the relationship to pain, opioid use, treatment, and psychosocial symptoms.

2021 ◽  
Vol 39 (28_suppl) ◽  
pp. 192-192
Author(s):  
Desiree Rachel Azizoddin ◽  
Mieke A. Soens ◽  
Meghan Beck ◽  
Kelsey Mikayla Flowers ◽  
Robert R. Edwards ◽  
...  

192 Background: Sleep disturbance negatively impacts quality of life and recovery. Our objective was to evaluate the relationship between individual patient factors (demographic, surgical, pain, opioid use, and psychosocial factors) and greater sleep disturbance. Methods: In this prospective longitudinal study, patients completed validated measures regarding their sleep disturbance, pain, opioid use, and psychological symptoms preoperatively and then 2 weeks, 6 and 12 months postoperatively. Objective pain sensitivity measures were evaluated at baseline using quantitative sensory testing. Univariable and multivariable generalized estimating equations (GEE) evaluated demographic, surgical, pain, and psychological predictors of sleep disturbance during the first year after surgery for breast cancer. Results: Female patients (n = 259) reported varying degrees of sleep disturbance, which were longitudinally associated with pain, psychosocial factors such as anxiety, depression, and affect. While the mean degree of sleep disturbance did not change substantially over time, the link to pain severity appeared to strengthen over the first postoperative year. Independent preoperative predictors of worse sleep disturbance on multivariable longitudinal GEE included younger age (B = -.09, p =.006), opioid use (B = 3.09, p =.02), higher pain (B =.19, p = <.001) and anxiety (B =.45, p = <.001) at baseline. On the other hand, higher basline positive affect (B = -.14, p = <.012) and the surgical category total mastectomy without reconstruction (B = -2.81, p = <.006) were indepently associated with lower sleep disturbance. Those with worse baseline sleep required more opioid analgesics during surgical recovery, and continued use of opioids at 2 weeks post-surgery was associated with disturbed sleep. Conclusions: Sleep disturbance in the first year following surgery for breast cancer varied substantially between individuals. Certain demographic, psychosocial, and pain factors explained more of this variance than surgical procedure, with the exception of total mastectomy without reconstruction that was associated with lower sleep disturbance. Sleep disturbance was associated with increased need for opioids in the perioperative period, and a propensity for more prolonged postoperative opioid use. Pre-surgical interventions in high risk individuals such as anxiety management, boosting positive affect, and controlling pain that have been shown to improve sleep quality could enhance postoperative recovery and decrease opioid use following breast surgery.

GYNECOLOGY ◽  
2018 ◽  
Vol 20 (1) ◽  
pp. 102-108
Author(s):  
Yu E Dobrokhotova ◽  
S E Arakelov ◽  
S Zh Danelyan ◽  
E I Borovkova ◽  
A E Zykov ◽  
...  

Associated with pregnancy is breast cancer, which was first detected during pregnancy, during the first year after childbirth or at any time against lactation. Diagnosis of the disease in the first trimester is an indication for abortion. The detection of the disease after 20 weeks and the desire of the woman to maintain pregnancy is the basis for conducting a total mastectomy followed by polychemotherapy with doxorubicin with cyclophosphamide or with fluorouracil. Radiation therapy during pregnancy is not applied. The timing and method of delivery are determined individually and depend on the stage of the process and the period of pregnancy, when it was identified. A clinical case of a patient with edematous-infiltrative form of breast cancer of the IV stage, diagnosed for the first time in 22 weeks of pregnancy, is presented.


2019 ◽  
Vol 76 (3) ◽  
pp. 393-402 ◽  
Author(s):  
Jason W Boland ◽  
Victoria Allgar ◽  
Elaine G Boland ◽  
Mike I Bennett ◽  
Stein Kaasa ◽  
...  

Abstract Purpose Opioids reduce cancer-related pain but an association with shorter survival is variably reported. Aim: To investigate the relationship between pain, analgesics, cancer and survival within the European Palliative Care Cancer Symptom (EPCCS) study to help inform clinical decision making. Methods Secondary analysis of the international prospective, longitudinal EPCCS study which included 1739 adults with advanced, incurable cancer receiving palliative care. In this secondary analysis, for all participants with date of death or last follow up, a multilevel Weibull survival analysis examined whether pain, analgesics, and other relevant variables are associated with time to death. Results Date of death or last follow-up was available for 1404 patients (mean age 65.7 [SD:12.3];men 50%). Secondary analysis of this group showed the mean survival from baseline was 46.5 (SD:1.5) weeks (95% CI:43.6–49.3). Pain was reported by 76%; 60% were taking opioids, 51% non-opioid analgesics and 24% co-analgesics. Opioid-use was associated with decreased survival in the multivariable model (HR = 1.59 (95% CI:1.38–1.84), p < 0.001). An exploratory subgroup analysis of those with C-reactive protein (CRP) measures (n = 219) indicated higher CRP was associated with poorer survival (p = 0.001). In this model, the strength of relationship between survival and opioid-use weakened (p = 0.029). Conclusion Opioid-use and survival were associated; this relationship weakened in a small sensitivity-testing subgroup analysis adjusting for CRP. Thus, the observed relationship between survival and opioid-use may partly be due to tumour-related inflammation. Larger studies, measuring disease activity, are needed to confirm this finding to more accurately judge the benefits and risks of opioids in advanced progressive disease.


1990 ◽  
Vol 16 (1) ◽  
pp. 5-14 ◽  
Author(s):  
Jeffrey R. Edwards ◽  
Cary L. Cooper ◽  
S. Gail Pearl ◽  
Ellen S. de Paredes ◽  
Tom O'Leary ◽  
...  

2016 ◽  
Vol 26 (1) ◽  
pp. 74-80 ◽  
Author(s):  
Varinka Voigt ◽  
Franziska Neufeld ◽  
Judith Kaste ◽  
Markus Bühner ◽  
Philipp Sckopke ◽  
...  

1997 ◽  
Vol 118 (3) ◽  
pp. 267-273 ◽  
Author(s):  
L. E. GREEN ◽  
E. BERRIATUA ◽  
K. L. MORGAN

A prospective longitudinal study of diseases of lambs born in December and January and housed through to slaughter was carried out on three flocks (A, B and C) between 1989 and 1991. In the first year of the investigation (1989–90) three cohorts of approximately 80 lambs were examined in detail on a regular (weekly or fortnightly) basis. This involved over 2000 examinations and at least one clinical abnormality was observed in each lamb. In the second year (1990–1) the farmers were asked to present sick lambs for treatment on the farm. Farmers from flocks A and B participated in this part of the study; a total of 97/1295 lambs that were slaughtered received at least one treatment.The carcases and visceral organs of lambs from each flock were observed after slaughter. There was no association between the abnormalities observed during routine examination of the cohort lambs (year 1) and those observed at post mortem meat inspection. However, in year 2, in lambs from flock A, there was a significant association between lambs treated for arthritis or pneumonia on the farm and the presence of arthritic or pleuritic lesions, respectively, post mortem. In both years of the study lambs which were older when slaughtered were significantly more likely to have pleuritic, pneumonic or arthritic lesions at meat inspection.It was concluded that routine examination of groups of lambs is an inefficient and possibly ineffective method to identify lambs with lesions at slaughter. However, lambs which have been treated for disease, and the older lambs in a flock, had an increased prevalence of lesions post mortem and hence more detailed inspection of these animals would increase the efficiency of meat inspection.


Sign in / Sign up

Export Citation Format

Share Document